Soleus Capital Management, L.P. Mirum Pharmaceuticals, Inc. Transaction History

Soleus Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$24.63 - $32.85 $1.8 Million - $2.4 Million	-73,000 Reduced 41.48%	103,000 $3.25 Million
Q2 2023 Aug 14, 2023	SELL	$23.51 - $30.09 $1.55 Million - $1.99 Million	-66,000 Reduced 27.27%	176,000 $4.55 Million
Q1 2023 May 15, 2023	BUY	$19.19 - $24.1 $4.64 Million - $5.83 Million	242,000 New	242,000 $5.81 Million
Q3 2022 Nov 14, 2022	SELL	$19.98 - $29.44 $1.21 Million - $1.78 Million	-60,400 Reduced 30.81%	135,618 $2.85 Million
Q2 2022 Aug 15, 2022	SELL	$18.42 - $27.5 $2.72 Million - $4.06 Million	-147,482 Reduced 42.94%	196,018 $3.82 Million
Q1 2022 May 16, 2022	BUY	$15.5 - $23.93 $5.32 Million - $8.22 Million	343,500 New	343,500 $7.56 Million

197

54.3M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.85B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.